Cliff Cramer
Director at Columbia Business School
Biography
Columbia Business School
Biography
Professor Cramer spent more than 25 years in the healthcare, pharmaceutical, and financial services sectors. He was Managing Director at Merrill Lynch in the Global Healthcare Investment Banking Group, and Managing Director at JPMorgan in the Corporate Finance Group providing M&A services and financing to global healthcare enterprises. Earlier, Prof. Cramer was Vice President, Corporate Planning & Development for Merck & Co., Inc. with worldwide responsibilities for strategic planning and business development. In addition, he was co-founder of American Health Capital / VHA Enterprises, Inc., a healthcare financial services company serving the capital needs of multihospital systems and managed care organizations, and held investment banking positions with Paine Webber, Inc., and L.F. Rothschild, Unterberg, Towbin, Inc. Prof. Cramer created the Healthcare and Pharmaceutical Management Program at CBS, and was director of the Program from its inception in 2006 to 2015. He was also the recipient of the Dean’s Award for Teaching Excellence in 2015.
Teaching
Spring 2018
Strategy and Competition in Pharmaceuticals and Biotechnology (MBA)
Spring 2017
Strategy and Competition in Pharmaceuticals and Biotechnology (MBA)
Spring 2016
Strategy and Competition in Pharmaceuticals and Biotechnology (MBA)
Spring 2015
Healthcare Investment and Entrepreneurship (MBA)
Strategy and Competition in Pharmaceuticals and Biotechnology (MBA)
Spring 2014
Strategy and Competition in Pharmaceuticals and Biotechnology (MBA)
Healthcare Investment and Dealmaking (MBA)
Fall 2013
Investing in Medical Technologies (MBA)
Spring 2013
Strategy and Competition in Pharmaceuticals and Biotechnology (MBA)
Healthcare Investment and Dealmaking (MBA)
Fall 2012
Pharmaceutical Development & Commercialization Workshop (MBA)
Spring 2012
Strategy and Competition in Pharmaceuticals and Biotechnology (MBA)
Healthcare Investment and Dealmaking (MBA)
Healthcare Business and Investment in Emerging Markets (MBA)
Columbia Caseworks cases
Benicar and Sankyo Pharma: Marketing Challenges of Launching Into a Crowded Pharmaceutical Market (2010)
Coauthor(s): Cliff Cramer
More Information
Read about executive education
Other experts
Finn Østrup
Presentation Finn Østrup is professor (mso) since 2008. He has written extensively on financial institutions, on financial crises, and on international monetary economics. Before joining Copenhagen Business School in 1990, Finn Østrup worked in the Danish Ministry of Economic Affairs, working i...
Matthew Billett
Academic Degrees PhD, University of Florida, 1993 BA, Colgate University, 1989 Professional Experience University of Iowa, Tippie College of Business, Professor of Finance, 1998-2011 University of Miami, Assistant Professor of Finance, 1996 – 1998 Federal Deposit Insurance Corporation, Washin...
Popular Courses
Leading Strategic Growth and Change
Columbia Business School
New York, New York, United States
Jun 10
Leading Digital Transformation
ESMT
Berlin, Germany
May 28
Leading People and Teams
ESMT
Berlin, Germany
May 28
Private Equity: Investing and Creating Value
The Wharton School
Philadelphia, Pennsylvania, United States
Sep 8
The Manchester Leadership Development Programme
Alliance Manchester Business School
Manchester, United Kingdom
Jul 1
The Positive Leader: Deep Change and Organizational Transformation
Stephen M. Ross School of Business
Ann Arbor, Michigan, United States
Jun 23
Looking for an expert?
Contact us and we'll find the best option for you.